The U.K. votes to leave the European Union. Heavy fighting continues in parts of Fallujah as Iraqi forces seek to retake all of the city from ISIS. And in Venezuela, food shortages spur looting and rioting. A panel of journalists joins guest host Susan Page for analysis of the week's top international news stories.
An FDA advisory board recommended withdrawing government approval for the breast cancer drug, Avastin. Pros and cons of the decision and its implications for FDA’s accelerated approval process to treat serious and life threatening diseases.
- Dr. Peter Bach attending physician and director of the Center for Health Policy and Outcomes at Memorial Sloan-Kettering Cancer Center, and a former adviser to Medicare.
- Dr. Carolyn Hendricks a medical oncologist affiliated with Suburban Hospital in Bethesda.
- William Hubbard former associate commissioner for the Food and Drug Administration; spokesperson for the Alliance for a Stronger FDA
- Gardiner Harris science reporter for "The New York Times" and author of the mystery novel 'Hazard.'
Most Recent Shows
The Friday News Roundup: House Democrats stage a sit-in to push for a vote on new gun laws. Campaign finance reports show Donald Trump with much less money and staff than Hillary Clinton. And a federal judge in Wyoming strikes down an Obama administration safety rule on fracking. A panel of journalists joins guest host Susan Page for analysis of the week's top national news stories.
An estimated six million people now go to health clinics each year in retail stores like CVS and Wal-Mart. But some doctors say relying too heavily on these convenient medical facilities can be risky. Guest host Susan Page and a panel of guests discuss the pros and cons of retail health clinics.
The Supreme Court votes 4-3 to uphold the affirmative action program at the University of Texas, and deadlocks on Obama's immigration plan. Jeffrey Rosen of The National Constitution Center joins Susan Page to discuss the implications of the rulings.